Drug Profile
Research programme: hepatitis C virus NS 5 protein inhibitors - Beta Pharma
Alternative Names: NS5A inhibitors - Beta PharmaLatest Information Update: 28 Dec 2020
Price :
$50
*
At a glance
- Originator Beta Pharma
- Class
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 28 Dec 2020 No recent reports of development identified for research development in Hepatitis-C in USA
- 09 Nov 2016 Early research in Hepatitis C in USA (unspecified route)